Entero Therapeutics, Inc. (GRDX) — 10-K Filings
All 10-K filings from Entero Therapeutics, Inc.. Browse 2 Annual Report reports with AI-powered summaries and risk analysis.
10-K Filings (2)
-
Entero Therapeutics Files 2024 10-K
— Apr 1, 2025 Risk: medium
Entero Therapeutics, Inc. filed its 2024 10-K on April 1, 2025, reporting its financial performance for the fiscal year ending December 31, 2024. The company, f -
First Wave BioPharma Files 2023 10-K, Details Financials and Strategic Events
— Mar 29, 2024 Risk: medium
First Wave BioPharma, Inc. (GRDX) filed a Annual Report (10-K) with the SEC on March 29, 2024. First Wave BioPharma, Inc. (formerly AzurRx BioPharma, Inc.) file
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX